Literature DB >> 23034251

Interleukin-9 and mast cells.

S Tete, A Saggini, G Maccauro, M Rosati, F Conti, E Cianchetti, D Tripodi, E Toniato, M Fulcheri, V Salini, A Caraffa, P Antinolfi, S Frydas, F Pandolfi, P Conti, G Potalivo, M Nicoletti, T C Theoharides.   

Abstract

Mast cells are granulated hematopoietic cells derived from stem cells that reside in nearly all tissues and are involved in protection of a host from bacterial infection with a protective and pathogenic activity. Mast cells are important for both innate and adaptive immunity in tissues which are in close contact with the environment. These cells express proinflammatory cytokines such as IL-1, IL-6, IL-8 and tumor necrosis factor which are necessary for innate immunity. Mast cells also produce interleukin-9 and enhance mast cell expression of several cytokines including IL-1beta, IL-5, IL-6, IL-9 and IL-13. In addition, IL-9 can induce mast cell production of TGF-beta which can have proinflammatory downstream effects. IL-9 can function as either a positive or a negative regulator of immune responses and can have a detrimental role in allergy and autoimmunity. Furthermore, IL-9 contributes to disease by promoting mast cell expansion and production of IL-13 which in turn contributes to airway hyperresponsiveness. Here, in this editorial we review the interrelationship between IL-9 and mast cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23034251

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  8 in total

1.  NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.

Authors:  Emilie Barruet; Blanca M Morales; Corey J Cain; Amy N Ton; Kelly L Wentworth; Tea V Chan; Tania A Moody; Mariëlle C Haks; Tom Hm Ottenhoff; Judith Hellman; Mary C Nakamura; Edward C Hsiao
Journal:  JCI Insight       Date:  2018-11-15

Review 2.  MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.

Authors:  Mehdi Sajjadi-Dokht; Talar Ahmad Merza Mohamad; Heshu Sulaiman Rahman; Marwah Suliman Maashi; Svetlana Danshina; Navid Shomali; Saeed Solali; Faroogh Marofi; Elham Zeinalzadeh; Morteza Akbari; Ali Adili; Ramin Aslaminabad; Majid Farshdousti Hagh; Mostafa Jarahian
Journal:  Genes Dis       Date:  2021-12-03

3.  Overexpression of IL-9 induced by STAT6 activation promotes the pathogenesis of chronic lymphocytic leukemia.

Authors:  Na Chen; Kang Lu; Peipei Li; Xiao Lv; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Roles of interleukin-9 in the growth and cholecystokinin-induced intracellular calcium signaling of cultured interstitial cells of Cajal.

Authors:  Yaoyao Gong; Lei Huang; Wenfang Cheng; Xueliang Li; Jia Lu; Lin Lin; Xinmin Si
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

5.  Increased expression of nuclear factor of activated T cells 1 drives IL-9-mediated allergic asthma.

Authors:  Sonja Koch; Anna Graser; Hooman Mirzakhani; Theodor Zimmermann; Volker O Melichar; Marco Wölfel; Damien C Croteau-Chonka; Benjamin A Raby; Scott T Weiss; Susetta Finotto
Journal:  J Allergy Clin Immunol       Date:  2016-03-15       Impact factor: 10.793

6.  Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions.

Authors:  Ajantha Sinniah; Samia Yazid; Stefania Bena; Sonia M Oliani; Mauro Perretti; Rod J Flower
Journal:  Front Pharmacol       Date:  2019-11-13       Impact factor: 5.810

Review 7.  Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Cosima T Baldari
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

8.  Interleukin-9 in Immunopathology of Trypanosoma cruzi Experimental Infection.

Authors:  Nadjania Saraiva de Lira Silva; Cristina Mary Orikaza; Fabiana Rodrigues de Santana; Luana Aguiar Dos Santos; Bruno Ramos Salu; Maria Luiza Vilela Oliva; Rita de Cássia Sinigaglia; Renato Arruda Mortara
Journal:  Front Cell Infect Microbiol       Date:  2021-10-15       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.